Dow Down0.92% Nasdaq Down0.83%

Cellular Biomedicine Group Inc. (CBMG)

-NasdaqCM
15.97 Up 0.03(0.19%) 3:54PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,070   274   286  
Cost of Revenue -   -   -  
Gross Profit 4,070   274   286  
Operating Expenses
Research Development1,891  3,214   -  
Selling General and Administrative11,047  4,121  1,322  
Non Recurring4,259   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (13,127) (7,062) (1,037)
Income from Continuing Operations
Total Other Income/Expenses Net(68)30  530  
Earnings Before Interest And Taxes(13,195)(7,032)(507)
Interest Expense258   -  10  
Income Before Tax(13,453)(7,032)(516)
Income Tax Expense344   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(13,797)(7,032)(464)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (13,797) (7,032) (516)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (13,797) (7,032) (516)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.